Online Exclusives

PolyPhotonix’s Noctura 400 Sleep Mask Helps Combat Diabetic Retinopathy

The Noctura 400 delivers a precise dose of light therapy during a patient’s normal hours of sleep.

Author Image

By: DAVID SAVASTANO

Contributing Editor, Coatings World and Ink World

The World Health Organisation regards diabetes as a global epidemic. The current global population of diabetics is estimated at 400 million and is set to grow to 500 million by 2020. In the UK alone, there are currently 4 million diabetics and this is expected to grow to 5.5 million by 2020. Currently more than 280,000 people a year are diagnosed with diabetes.   One of the impacts of diabetes is diabetic retinopathy (DR), a disease caused by diabetes. DR is one of the most common causes of blin...

Continue reading this story and get 24/7 access to Ink World magazine for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Ink World magazine Newsletters